1. Organisation mondiale de la Santé. Protocole d’enquête séroépidémiologique sur l’infection par le virus de la COVID-19 par tranche d’âge dans la population, 17 mars 2020 [Internet]. Organisation mondiale de la Santé; 2020 [cited 2022 Apr 26]. Report No.: WHO/2019-nCoV/Seroepidemiology/2020.1. Available from: https://apps.who.int/iris/handle/10665/331526
2. COVID-19 étude population (SEROCoV-POP) - Etude de l’Unité d’épidémiologie populationnelle (UEP) | HUG - Hôpitaux Universitaires de Genève [Internet]. [cited 2022 Apr 26]. Available from: https://www.hug.ch/medecine-premier-recours/covid-19-etude-population-serocov-pop
3. Coronavirus disease (COVID-19): Serology, antibodies and immunity [Internet]. [cited 2022 Apr 26]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-serology
4. Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. 2021 Jan;102:63–9.
5. Bajema KL, Wiegand RE, Cuffe K, Patel SV, Iachan R, Lim T, et al. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Internal Medicine. 2021 Apr;181(4):450.
6. Gümüş HH, Demiroğlu YZ, Alışkan HE, Ödemiş İ, Ceylan Ö, Poçan AG, et al. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic]. Mikrobiyol Bul. 2021 Jul;55(3):357–73.
7. Somboro AM, Cissoko Y, Camara I, Kodio O, Tolofoudie M, Dembele E, et al. High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali. Viruses. 2022 Jan 7;14(1):102.
8. Martin C, Montesinos I, Dauby N, Gilles C, Dahma H, Van Den Wijngaert S, et al. Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff. J Hosp Infect. 2020 Sep;106(1):102–6.
9. Alharbi NK, Alghnam S, Algaissi A, Albalawi H, Alenazi MW, Albargawi AM, et al. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. J Infect Public Health. 2021 Jul;14(7):832–8.
10. Rusakaniko S, Sibanda EN, Mduluza T, Tagwireyi P, Dhlamini Z, Ndhlovu CE, et al. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe. PLoS Negl Trop Dis. 2021 Mar;15(3):e0009254.
11. Santosh CS, Tukaram DP, Maharudra K, Balkrishna A, Chinmay G, Aniket I, et al. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers. J Assoc Physicians India. 2021 Aug;69(8):11–2.
12. Sauré D, O’Ryan M, Torres JP, Zuniga M, Santelices E, Basso LJ. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis. 2022 Jan;22(1):56–63.
13. Gümüş HH, Demiroğlu YZ, Alışkan HE, Ödemiş İ, Ceylan Ö, Poçan AG, et al. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic]. Mikrobiyol Bul. 2021 Jul;55(3):357–73.
14. Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, et al. Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021. Euro Surveill. 2021 Oct;26(43).
15. Wilkins JT, Gray EL, Wallia A, Hirschhorn LR, Zembower TR, Ho J, et al. Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago. Open Forum Infect Dis. 2021 Jan;8(1):ofaa582.
16. Sotgiu G, Barassi A, Miozzo M, Saderi L, Piana A, Orfeo N, et al. SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital. BMC Pulm Med. 2020 Jul 29;20(1):203.
17. Varona JF, Madurga R, Peñalver F, Abarca E, Almirall C, Cruz M, et al. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain. Int J Epidemiol. 2021 May 17;50(2):400–9.
18. Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 2021 Nov 17;375:e068302.
19. Kampf G, Brüggemann Y, Kaba HEJ, Steinmann J, Pfaender S, Scheithauer S, et al. Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2. J Hosp Infect. 2020 Dec;106(4):678–97.
20. Atangana E, Atangana A. Facemasks simple but powerful weapons to protect against COVID-19 spread: Can they have sides effects? Results Phys. 2020 Dec;19:103425.
21. Wiggen TD, Bohn B, Ulrich AK, Stovitz SD, Strickland AJ, Naumchik BM, et al. SARS-CoV-2 seroprevalence among healthcare workers. PLOS ONE. avr 2022;17(4):e0266410.